Blue Light: Clinical Trials

2 trials of Blue Light, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1

Follow Blue Light: new trials by email Literature Review of Blue Light trials Research Report on Blue Light

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating Photodynamic Therapy Used to Treat Cutaneous Squamous Cell Carcinoma in Situ (isSCC) on the Face, Upper Extremities & Trunk.
Aminolevulinic Acid 20% Topical Solution with Blue Light (dose 20 J/cm2), Aminolevulinic Acid 20% Topical Solution with Blue Light (dose 10 J/cm2) - Cutaneous Squamous Cell Carcinoma in Situ, Facial Cutaneous Squamous Cell Carcinoma in Situ
Phase 2RecruitingThe Center for Clinical and Cosmetic Research302025-11-252026-11-12
Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (isSCC)
Aminolevulinic Acid 20% Topical Solution with Blue Light - Facial Cutaneous Squamous Cell Carcinoma in Situ
Phase 2CompletedThe Center for Clinical and Cosmetic Research322023-08-082025-02-12

Conditions studied

Carcinoma, Squamous Cell (2)  ·  Skin Neoplasms (2)  ·  Squamous Intraepithelial Lesions (2)

Sponsors

The Center for Clinical and Cosmetic Research (2)

Countries

United States (2)

Top investigators

Mark S Nestor, MD, PhD (2)